For moderate persistent asthmatics that remain symptomatic on long-term anti-inflammatory inhaled corticosteroid (ICS) plus a long-acting beta2-agonist bronchodilator (LABA), the addition of inhaled tiotropium a long-acting anticholinergic agent, may provide additional efficacy in sub optimally controlled moderate persistent asthmatics.
http://ift.tt/2zdWVGD
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου